- Published on
KembaraXtra-Emergency And Acute Medicine: Hydrocarbon Poisoning
Basics
Description The most serious complication of hydrocarbon exposure is aspiration, primarily affecting the respiratory and central nervous systems. Toxicity is influenced by physical properties. Viscosity: lower viscosity increases aspiration risk. Volatility: highly volatile substances displace alveolar oxygen, leading to hypoxia. Surface tension: low surface tension facilitates spread from the oropharynx into the trachea, increasing aspiration risk (e.g., mineral oil, seal oil). Volatile-substance abuse commonly involves solvents such as typewriter correction fluid, adhesives, gasoline, and lighter fluid. Methods include sniffing (direct inhalation), huffing (from a soaked rag), and bagging (from a bag). Major hydrocarbon classes include aliphatics (kerosene, mineral oil, gasoline, solvents, paint thinners) causing pulmonary toxicity via aspiration and asphyxiation from methane or butane; halogenated hydrocarbons (carbon tetrachloride, trichloroethane) used industrially, well absorbed, and associated with hepatic and renal failure; aromatic or cyclic hydrocarbons (toluene, xylene) that are highly volatile and systemically absorbed, with fatal benzene ingestion reported at ~15 mL; and terpenes or wood distillates (turpentine, pine oil) causing significant gastrointestinal absorption and CNS depression.
Etiology Accidental exposure is most common in young children, while inhalant abuse and intentional self-harm are more frequent in adolescents and adults.
Diagnosis
Signs and symptoms Patients may be asymptomatic initially and often have a hydrocarbon odor on the breath. Early effects include euphoria and disinhibition; later effects include dysphoria, ataxia, confusion, and hallucinations. Sudden sniffing death can occur in volatile-substance abusers due to malignant dysrhythmias from myocardial sensitization. Pulmonary manifestations range from mild respiratory distress to cyanosis and aspiration pneumonitis. CNS effects include intoxication, slurred speech, lethargy, and coma. Gastrointestinal findings include mucosal irritation, gastritis, and diarrhea. Cardiac effects include tachycardia and dysrhythmias. Dermal findings include erythema, maculopapular or vesicular eruptions, defatting dermatitis, and “huffer face” rash with chronic exposure.
History Assess route, substance, amount, timing, intent, possible coingestions, symptoms, and any prehospital interventions.
Physical exam Evaluate airway protection in patients with vomiting or decreased consciousness. Respiratory symptoms usually appear within 30 minutes but may be delayed. Monitor for hypoxia, hypotension, and dysrhythmias. Early fever suggests chemical pneumonitis, whereas fever after 48 hours suggests secondary infection.
Essential workup Identify the exact product, manufacturer, ingredients, exposure type, and estimated quantity; review MSDS when applicable.
Diagnosis tests and interpretation
Laboratory Obtain ECG in volatile-substance abusers. Use pulse oximetry and ABG if abnormal. Check electrolytes, BUN, creatinine, glucose, and liver function tests for halogenated or aromatic exposures; metabolic acidosis and hypokalemia may be present. Measure carboxyhemoglobin for methylene chloride exposure.
Imaging Chest radiograph abnormalities may appear from 20 minutes to 24 hours (typically by 6 hours) and include increased bronchovascular markings with bibasilar or perihilar infiltrates. Lobar consolidation is uncommon; pneumothorax, pneumomediastinum, pleural effusion, and pneumatoceles are rare. Repeat imaging if respiratory status worsens.
Differential diagnosis Caustic ingestion, pesticide poisoning, toxic alcohol ingestion, assessment of accidental versus intentional exposure (psychiatric evaluation), and possible child neglect.
Treatment
Prehospital Remove contaminated clothing and decontaminate exposed skin and hair. Do not induce emesis; ipecac is contraindicated. Keep volatile-substance abusers calm and minimize agitation. Selected asymptomatic patients with known products and reliable observation may be managed at home.
Initial stabilization Follow ABCs, establish IV access with fluids if needed, administer oxygen, monitor cardiac rhythm, and give naloxone, thiamine, and dextrose for altered mental status as indicated.
Emergency department management Provide supportive care. Treat bronchospasm with oxygen and nebulized albuterol; intubate and ventilate for respiratory failure. Steroids are not recommended. Avoid epinephrine in volatile-substance abusers due to dysrhythmia risk. Alert Gastric decontamination is generally not indicated because aspiration risk outweighs benefit. Avoid if spontaneous emesis occurred. Consider limited gastric aspiration only for select CHAMP ingestions (camphor, halogenated hydrocarbons, aromatic hydrocarbons, metals, pesticides) within 60 minutes, with airway protection if needed. Activated charcoal and cathartics are not recommended.
Medication Albuterol 2.5–5 mg nebulized (pediatrics 0.15–0.3 mg/kg). Dextrose D50W 25 g IV (pediatrics D25W 2–4 mL/kg). Naloxone 2 mg IV or IM (pediatrics 0.1 mg/kg). Thiamine 100 mg IV or IM (pediatrics 50 mg).
Follow-up and disposition
Admission criteria Symptomatic patients or those at risk for delayed organ toxicity.
Discharge criteria Observe for at least 6 hours; discharge asymptomatic patients with normal pulse oximetry and chest radiograph, or those asymptomatic with abnormal imaging but normal oxygenation if reliable follow-up is ensured. Observe volatile-substance abusers until mental status normalizes.
Follow-up recommendations Reassess within 24 hours for patients who remain asymptomatic after observation. Repeat chest radiograph in 24 hours for asymptomatic patients with initial abnormalities.
Key points Aspiration is the dominant hazard in hydrocarbon exposure, with risk rising as viscosity and surface tension decrease and volatility increases. Prompt external decontamination is essential. Gastric decontamination and induced emesis are rarely appropriate. All patients should be observed for at least 6 hours, with hospital admission for those who are symptomatic or at risk for delayed toxicity.
Basics
Description The most serious complication of hydrocarbon exposure is aspiration, primarily affecting the respiratory and central nervous systems. Toxicity is influenced by physical properties. Viscosity: lower viscosity increases aspiration risk. Volatility: highly volatile substances displace alveolar oxygen, leading to hypoxia. Surface tension: low surface tension facilitates spread from the oropharynx into the trachea, increasing aspiration risk (e.g., mineral oil, seal oil). Volatile-substance abuse commonly involves solvents such as typewriter correction fluid, adhesives, gasoline, and lighter fluid. Methods include sniffing (direct inhalation), huffing (from a soaked rag), and bagging (from a bag). Major hydrocarbon classes include aliphatics (kerosene, mineral oil, gasoline, solvents, paint thinners) causing pulmonary toxicity via aspiration and asphyxiation from methane or butane; halogenated hydrocarbons (carbon tetrachloride, trichloroethane) used industrially, well absorbed, and associated with hepatic and renal failure; aromatic or cyclic hydrocarbons (toluene, xylene) that are highly volatile and systemically absorbed, with fatal benzene ingestion reported at ~15 mL; and terpenes or wood distillates (turpentine, pine oil) causing significant gastrointestinal absorption and CNS depression.
Etiology Accidental exposure is most common in young children, while inhalant abuse and intentional self-harm are more frequent in adolescents and adults.
Diagnosis
Signs and symptoms Patients may be asymptomatic initially and often have a hydrocarbon odor on the breath. Early effects include euphoria and disinhibition; later effects include dysphoria, ataxia, confusion, and hallucinations. Sudden sniffing death can occur in volatile-substance abusers due to malignant dysrhythmias from myocardial sensitization. Pulmonary manifestations range from mild respiratory distress to cyanosis and aspiration pneumonitis. CNS effects include intoxication, slurred speech, lethargy, and coma. Gastrointestinal findings include mucosal irritation, gastritis, and diarrhea. Cardiac effects include tachycardia and dysrhythmias. Dermal findings include erythema, maculopapular or vesicular eruptions, defatting dermatitis, and “huffer face” rash with chronic exposure.
History Assess route, substance, amount, timing, intent, possible coingestions, symptoms, and any prehospital interventions.
Physical exam Evaluate airway protection in patients with vomiting or decreased consciousness. Respiratory symptoms usually appear within 30 minutes but may be delayed. Monitor for hypoxia, hypotension, and dysrhythmias. Early fever suggests chemical pneumonitis, whereas fever after 48 hours suggests secondary infection.
Essential workup Identify the exact product, manufacturer, ingredients, exposure type, and estimated quantity; review MSDS when applicable.
Diagnosis tests and interpretation
Laboratory Obtain ECG in volatile-substance abusers. Use pulse oximetry and ABG if abnormal. Check electrolytes, BUN, creatinine, glucose, and liver function tests for halogenated or aromatic exposures; metabolic acidosis and hypokalemia may be present. Measure carboxyhemoglobin for methylene chloride exposure.
Imaging Chest radiograph abnormalities may appear from 20 minutes to 24 hours (typically by 6 hours) and include increased bronchovascular markings with bibasilar or perihilar infiltrates. Lobar consolidation is uncommon; pneumothorax, pneumomediastinum, pleural effusion, and pneumatoceles are rare. Repeat imaging if respiratory status worsens.
Differential diagnosis Caustic ingestion, pesticide poisoning, toxic alcohol ingestion, assessment of accidental versus intentional exposure (psychiatric evaluation), and possible child neglect.
Treatment
Prehospital Remove contaminated clothing and decontaminate exposed skin and hair. Do not induce emesis; ipecac is contraindicated. Keep volatile-substance abusers calm and minimize agitation. Selected asymptomatic patients with known products and reliable observation may be managed at home.
Initial stabilization Follow ABCs, establish IV access with fluids if needed, administer oxygen, monitor cardiac rhythm, and give naloxone, thiamine, and dextrose for altered mental status as indicated.
Emergency department management Provide supportive care. Treat bronchospasm with oxygen and nebulized albuterol; intubate and ventilate for respiratory failure. Steroids are not recommended. Avoid epinephrine in volatile-substance abusers due to dysrhythmia risk. Alert Gastric decontamination is generally not indicated because aspiration risk outweighs benefit. Avoid if spontaneous emesis occurred. Consider limited gastric aspiration only for select CHAMP ingestions (camphor, halogenated hydrocarbons, aromatic hydrocarbons, metals, pesticides) within 60 minutes, with airway protection if needed. Activated charcoal and cathartics are not recommended.
Medication Albuterol 2.5–5 mg nebulized (pediatrics 0.15–0.3 mg/kg). Dextrose D50W 25 g IV (pediatrics D25W 2–4 mL/kg). Naloxone 2 mg IV or IM (pediatrics 0.1 mg/kg). Thiamine 100 mg IV or IM (pediatrics 50 mg).
Follow-up and disposition
Admission criteria Symptomatic patients or those at risk for delayed organ toxicity.
Discharge criteria Observe for at least 6 hours; discharge asymptomatic patients with normal pulse oximetry and chest radiograph, or those asymptomatic with abnormal imaging but normal oxygenation if reliable follow-up is ensured. Observe volatile-substance abusers until mental status normalizes.
Follow-up recommendations Reassess within 24 hours for patients who remain asymptomatic after observation. Repeat chest radiograph in 24 hours for asymptomatic patients with initial abnormalities.
Key points Aspiration is the dominant hazard in hydrocarbon exposure, with risk rising as viscosity and surface tension decrease and volatility increases. Prompt external decontamination is essential. Gastric decontamination and induced emesis are rarely appropriate. All patients should be observed for at least 6 hours, with hospital admission for those who are symptomatic or at risk for delayed toxicity.
0 Comments
